Jennison Associates LLC Arbutus Biopharma Corp Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$1.75 - $6.2 $594,368 - $2.11 Million	-339,639 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$0.91 - $2.36 $13,765 - $35,699	-15,127 Reduced 4.26%	339,639 $618,000
Q1 2020 May 06, 2020	SELL	$1.01 - $3.42 $2.61 Million - $8.85 Million	-2,589,023 Reduced 87.95%	354,766 $358,000
Q4 2019 Feb 07, 2020	BUY	$0.87 - $2.89 $1.9 Million - $6.3 Million	2,178,665 Added 284.75%	2,943,789 $8.18 Million
Q3 2019 Nov 08, 2019	BUY	$1.34 - $2.4 $183,747 - $329,100	137,125 Added 21.84%	765,124 $1.17 Million
Q2 2019 Aug 06, 2019	BUY	$1.46 - $4.44 $916,878 - $2.79 Million	627,999 New	627,999 $0
Q4 2018 Feb 06, 2019	SELL	$3.5 - $9.66 $943,946 - $2.61 Million	-269,699 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$7.85 - $12.35 $2.12 Million - $3.33 Million	269,699 New	269,699 $2.55 Million

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.